With seizure drug held up at FDA again, Aque­s­tive re­places long­time CEO

The C-suite mu­si­cal chairs re­ver­ber­at­ing through biotech the last few months con­tin­ued Tues­day af­ter­noon with an­oth­er small cap com­pa­ny an­nounc­ing a tran­si­tion at the top …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER